Invitae Corp
NVTADelisted- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001501134
Invitae Corp was delisted in 2024; its insiders filed their last Form 4 on Dec 21, 2023; 204 institutions reported holding it in 13F filings for Q4 2023, worth $100.6M in total; ARK Invest was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 203
- Q4 2023, −13 vs. previous quarter
- 13F value
- $97.7M
- Reported value at the end of Q4 2023
- Superinvestors holding
- 1
- At the end of Q4 2023
Superinvestors holding NVTA, Q4 2023
1 superinvestor reports holding Invitae Corp on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Invitae Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −7.09K | $1.38 | −$9.78K | −1.2%569.3K after | |
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Brida ThomasSee Remarks | SSale | −7.08K | $1.38 | −$9.77K | −1.0%704.1K after | |
| May 24, 2023 (view filing) | May 16 | 8 days | Wen YafeiChief Financial Officer | SSale | −43.5K | $1.20 | −$52.1K | −5.8%700.3K after | Amended |
| May 18, 2023 (view filing) | May 16 | 2 days | Knight Kenneth D.Chief Executive Officer | SSale | −45.4K | $1.20 | −$54.5K | −2.6%1.67M after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −26.5K | $1.20 | −$31.8K | −4.4%576.4K after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Werner Robert F.Chief Accounting Officer | SSale | −21.6K | $1.20 | −$25.9K | −5.7%354.7K after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Brida ThomasSee Remarks | SSale | −26.5K | $1.20 | −$31.8K | −3.6%711.2K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Brida ThomasSee Remarks | SSale | −2.63K | $1.41 | −$3.70K | −0.6%437.6K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −2.63K | $1.41 | −$3.70K | −0.6%447.9K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Wen YafeiChief Financial Officer | SSale | −2.63K | $1.41 | −$3.70K | −0.6%443.7K after |
Top 10 13F holders, Q4 2023
The largest institutional positions in Invitae Corp at the end of Q4 2023; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 32,550,683 | $20.4M | 0.12% | −391,923−1.2% | Reduced |
| BlackRock Inc. | 19,258,772 | $12.1M | 0.00% | −1,539,207−7.4% | Reduced |
| Nikko Asset Management Americas, Inc. | 16,764,480 | $10.6M | 0.10% | 00.0% | Unchanged |
| Sumitomo Mitsui Trust Holdings, Inc. | 16,764,480 | $10.5M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 14,660,153 | $9.19M | 0.00% | +1,132,646+8.4% | Added |
| State Street Corp | 6,177,962 | $3.87M | 0.00% | −1,780,985−22.4% | Reduced |
| Geode Capital Management, LLC | 5,574,850 | $3.49M | 0.00% | +450,651+8.8% | Added |
| D. E. Shaw & Co., Inc. | 3,070,708 | $1.92M | 0.00% | +2,629,153+595.4% | Added |
| Northern Trust Corp | 2,311,047 | $1.45M | 0.00% | +69,558+3.1% | Added |
| Renaissance Technologies LLC | 2,197,698 | $1.38M | 0.00% | +2,197,698 | New |